Epistasis of the DRD2/ANKK1 Taq Ia and the BDNF Val66Met polymorphism impacts Novelty Seeking and Harm Avoidance - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Neuropsychopharmacology Année : 2010

Epistasis of the DRD2/ANKK1 Taq Ia and the BDNF Val66Met polymorphism impacts Novelty Seeking and Harm Avoidance

Résumé

Mounting evidence from animal studies show that the mesolimbic dopaminergic pathways are modulated by the brain derived neurotrophic factor (BDNF). This study investigates in N = 768 healthy Caucasian participants the influence of two prominent functional single nucleotide polymorphisms (SNPs) on the BDNF gene (BDNF Val66Met SNP) and the ANKK1 gene (DRD2 Taq Ia / ANKK1 SNP) on the personality traits of Novelty Seeking and Harm Avoidance, which are mediated, in part, through dopaminergic mesolimbic circuitry. Carriers of the 66Met+/A1+ variant scored lowest on Novelty Seeking and highest on Harm Avoidance, compared to all other genotype groups. These participants are characterized by a relatively low D2 receptor density in the striatum and an impaired activity-dependent secretion of BDNF. This is one of the first genetic association studies to demonstrate a modulatory role for BDNF genetic variation on genetically mediated differences in the mesolimbic dopaminergic system in the context of human personality
Fichier principal
Vignette du fichier
PEER_stage2_10.1038%2Fnpp.2010.55.pdf (256.44 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-00528087 , version 1 (21-10-2010)

Identifiants

Citer

Christian Montag, Sebastian Markett, Ulrike Basten, Christine Stelzel, Christian Fiebach, et al.. Epistasis of the DRD2/ANKK1 Taq Ia and the BDNF Val66Met polymorphism impacts Novelty Seeking and Harm Avoidance. Neuropsychopharmacology, 2010, ⟨10.1038/npp.2010.55⟩. ⟨hal-00528087⟩

Collections

PEER
166 Consultations
172 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More